Yung‐Hung Luo

2.3k citations

61 papers · 1.4k indexed · 1 hit paper · h-index 16

Infectious Diseases top 5%
Cancer Research top 10%
- Cancer Genomics and Diagnostics 8
Pulmonary and Respiratory Medicine top 10%
- Lung Cancer Treatments and Mutations 36
- Brain Metastases and Treatment 11
- Lung Cancer Diagnosis and Treatment 7
Oncology top 10%
- Lung Cancer Research Studies 27
- Colorectal Cancer Treatments and Studies 7
- Cancer Immunotherapy and Biomarkers 6
Neurology top 10%
Epidemiology
- Neuroendocrine Tumor Research Advances 6

Co-authors: Mong‐Lien Wang Aliaksandr A. Yarmishyn Chian‐Shiu Chien Wei-Yi Lai Yi‐Ping Yang Yuh-Min Chen Shih‐Jie Chou Yi‐Tsung Lin
Cited by: Infectious Diseases Cancer Research Pulmonary and Respiratory Medicine
Partner nations: Taiwan United States China

In The Last Decade

Yung‐Hung Luo

54 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Yung‐Hung Luo

Since Specialization

Citations

This map shows the geographic impact of Yung‐Hung Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yung‐Hung Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yung‐Hung Luo more than expected).

Fields of papers citing papers by Yung‐Hung Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yung‐Hung Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yung‐Hung Luo. The network helps show where Yung‐Hung Luo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yung‐Hung Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yung‐Hung Luo Line = papers co-authored together Yung‐Hung Luo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	BBB-penetrant tyrosine kinase inhibitor plus intracranial radiotherapy vs BBB-penetrant TKI alone in Asians with EGFR-mutated lung adenocarcinoma and brain metastases You-Cong Chen,Chun‐Fu Lin,Chi‐Lu Chiang,Huai‐Che Yang,Hsiu‐Mei Wu,Ching‐Jen Chen,Yung‐Hung Luo,Yong-Sin Hu,Chung‐Jung Lin,Wen‐Yuh Chung,Cheng‐Ying Shiau,Wan‐Yuo Guo,David Hung‐Chi Pan,Cheng‐Chia Lee	2025	0
2	Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors J. Nicholas Bodor,Jonathan E. Dowell,Joseph Treat,Janakiraman Subramanian,Nihal Abdulla,Eric Lee,Kamalesh K. Sankhala,Chun‐Hui Lee,Go Makimoto,Eisaku Miyauchi,Kartik Konduri,Hajime Asahina,Shuji Murakami,Yueh‐Feng Wen,Yung‐Hung Luo,Sung‐Joon Chang,Reginald B. Ewesuedo,Jianli Zhou,Yasushi Goto	2025	1
3	Targeted therapy‑associated cardiotoxicity in patients with stage‑IV lung cancer with or without cardiac comorbidities Yanmei Peng,Dong Li,Jason A. Wampfler,Yung‐Hung Luo,Ashok Kumar,Zhong Gu,Nikhila Kosuru,Nathan Y. Yu,Zhichao Wang,Konstantinos Leventakos,Vinicius Ernani,Ping Yang	2024	3
4	Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience Chun‐Wei Lu,Chun‐Bing Chen,Tsu‐Man Chiu,Chih‐Chiang Chen,Kai-Che Wei,Shang-Hung Lin,Sebastian Yu,Chao‐Kai Hsu,Pa‐Fan Hsiao,Pei-Sung Hsu,Jian Su,Sheau‐Chiou Chao,Cheng‐Ta Yang,Wen‐Hung Chung,Yung‐Hung Luo	2024	0
5	TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy Shixiang Wang,Yi Xiong,Yihao Zhang,Haitao Wang,Minjun Chen,Jianfeng Li,Peng Luo,Yung‐Hung Luo,Markus Hecht,Benjamin Frey,Udo S. Gaipl,Xuejun Li,Qi Zhao,Hu Ma,Jian‐Guo Zhou	2024	7
6	Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer Jin‐Yuan Shih,Yung‐Hung Luo,Gee‐Chen Chang,John Wen‐Cheng Chang,C.-C. Wang,Tsung‐Ying Yang,Wei‐Tse Fang,Wen‐Yi Shau	2024	3
7	Registry of Genetic Alterations of Taiwan Non–Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521 Bin-Chi Liao,Nai-Jung Chiang,Gee-Chen Chang,Wu‐Chou Su,Yung‐Hung Luo,Inn‐Wen Chong,Tsung‐Ying Yang,Chun-Liang Lai,Te‐Chun Hsia,Ching‐Liang Ho,Kang‐Yun Lee,Chin‐Fu Hsiao,Fan-Chen Ku,Wei‐Tse Fang,James Chih‐Hsin Yang	2024	2
8	Immune signatures of patients with advanced non-small-cell lung cancer for efficacy prediction after immunotherapy Yung‐Hung Luo,Chia‐I Shen,Chi‐Lu Chiang,Yuh-Min Chen	2024	1
9	Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids Yuan‐Hung Wu,Heng‐Sheng Chao,Chi‐Lu Chiang,Yung‐Hung Luo,Chao‐Hua Chiu,Sang‐Hue Yen,Chun‐Yu Liu,Jeng‐Fong Chiou,Thierry Burnouf,Yin‐Ju Chen,Peng‐Yuan Wang,Tsu‐Yi Chao,Shih‐Ming Hsu,Long‐Sheng Lu	2023	4
10	State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan Yung‐Hung Luo,Kung‐Hao Liang,Hsu-Ching Huang,Chia‐I Shen,Chi‐Lu Chiang,Mong‐Lien Wang,Shih‐Hwa Chiou,Yuh‐Min Chen	2022	7
11	EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases Hung-Ruei Liao,Chi‐Lu Chiang,Chia‐I Shen,Ching‐Jen Chen,Huai‐Che Yang,Hsiu‐Mei Wu,Yung‐Hung Luo,Yong-Sin Hu,Chung‐Jung Lin,Wen‐Yuh Chung,Cheng-Ying Shiau,Wan‐Yuo Guo,David Hung‐Chi Pan,Cheng‐Chia Lee	2022	0
12	RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases Pai‐Chi Teng,Yanwen Liang,Aliaksandr A. Yarmishyn,Yu‐Jer Hsiao,Ting‐Yi Lin,Tzu-Wei Lin,Yuan‐Chi Teng,Yi-Ping Yang,Mong‐Lien Wang,Chian‐Shiu Chien,Yung‐Hung Luo,Yuh-Min Chen,Po‐Kuei Hsu,Shih-Hwa Chiou,Yueh Chien	2021	100
13	Circular RNA hsa_circ_0000190 Facilitates the Tumorigenesis and Immune Evasion by Upregulating the Expression of Soluble PD-L1 in Non-Small-Cell Lung Cancer Yung‐Hung Luo,Yi‐Ping Yang,Chian‐Shiu Chien,Aliaksandr A. Yarmishyn,Afeez Adekunle Ishola,Yueh Chien,Yuh‐Min Chen,Ping‐Hsing Tsai,Tzu-Wei Lin,Mong‐Lien Wang,Shih‐Hwa Chiou	2021	34
14	Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation Yung‐Hung Luo,Han Liu,Jason A. Wampfler,Henry D. Tazelaar,Yalun Li,Tobias Peikert,Dan Liu,Konstantinos Leventakos,Yuh-Min Chen,Yanan Yang,Shih-Hwa Chiou,Ping Yang	2021	3
15	Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis Chi‐Lu Chiang,Cheng‐Chia Lee,Hsu-Ching Huang,Chia‐Hung Wu,Yi‐Chen Yeh,Chia‐I Shen,Yung‐Hung Luo,Tsu‐Hui Shiao,Han Chang,Yu-Ting Huang,Yuh‐Min Chen,Teh-Ying Chou,Chao‐Hua Chiu	2021	13
16	Plasma Level of Circular RNA hsa_circ_0000190 Correlates with Tumor Progression and Poor Treatment Response in Advanced Lung Cancers Yung‐Hung Luo,Yi-Ping Yang,Chian‐Shiu Chien,Aliaksandr A. Yarmishyn,Afeez Adekunle Ishola,Yueh Chien,Yuh-Min Chen,Tsai‐Wang Huang,Kang‐Yun Lee,Wen-Chien Huang,Ping‐Hsing Tsai,Tzu-Wei Lin,Shih-Hwa Chiou,Chao-Yu Liu,Cheng‐Chang Chang,Ming-Teh Chen,Mong‐Lien Wang	2020	55
17	Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy Chia‐I Shen,Hsu-Ching Huang,Chi‐Lu Chiang,Yung‐Hung Luo,Tsu‐Hui Shiao,Chao‐Hua Chiu	2019	4
18	Critical Appraisal of Gefitinib in the Treatment of Non-Small Cell Lung Cancer Yung‐Hung Luo,Yu‐Chin Lee,Jacqueline Whang‐Peng,Yuh‐Min Chen	2015	2
19	Association between Tumor Epidermal Growth Factor Receptor Mutation and Pulmonary Tuberculosis in Patients with Adenocarcinoma of the Lungs Yung‐Hung Luo,Chieh‐Hung Wu,Wen-Shuo Wu,Chu‐Yun Huang,Wei‐Juin Su,Chun‐Ming Tsai,Yu‐Chin Lee,Reury-Perng Perng,Yuh‐Min Chen	2011	49
20	Tratamiento con ribavirina inhalada en el síndrome de dificultad respiratoria aguda inducida por virus respiratorio sincitial en el adulto Yung‐Hung Luo,Chu-Yun Huang,Kuang‐Yao Yang,Yu-Chin Lee	2011	7

About Yung‐Hung Luo

Yung‐Hung Luo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 61 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (36 papers), Lung Cancer Research Studies (27 papers), Brain Metastases and Treatment (11 papers), Cancer Genomics and Diagnostics (8 papers), Colorectal Cancer Treatments and Studies (7 papers), Lung Cancer Diagnosis and Treatment (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Infectious Diseases (552 citations), Cancer Research (247 citations) and Pulmonary and Respiratory Medicine (386 citations). Yung‐Hung Luo has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Mong‐Lien Wang, Aliaksandr A. Yarmishyn, Chian‐Shiu Chien, Wei-Yi Lai, Yi‐Ping Yang, Yuh-Min Chen, Shih‐Jie Chou, Yi‐Tsung Lin, Yi‐Ying Lin and De‐Ming Yang.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact